B-I09 potently suppressed XBP1 activity and triggered apoptosis in CLL cells, and effectively attenuated leukemic progression in CLL-bearing Eμ-TCL1 mice, without inducing systemic toxicity. The gene discussed is XBP1; the disease is B-cell chronic lymphocytic leukemia.